Funding @ 2024-06-16 02:43:54 UTC e73a3fa17eb1536097e750b14b3ab452e493656a9dfd5a9d844b4453ed4c45d2:0
Spending @ 2024-06-17 10:51:31 UTC c5a4b87b1fad35d5309344e8ab435f2e33d5d0bec2e059861f223726a9b2a4e8:43
|
Funding @ 2024-05-30 02:50:06 UTC ac1dea950958ee20c78980db1652d82c46a1882736019ddcfe7f660d676606b1:0
Spending @ 2024-06-16 12:27:10 UTC 62166abc124a9d4252025192b8c1ad352f1599e93b1173055a39756490d8e6ba:83
|
Funding @ 2024-05-24 01:17:28 UTC 221690db7a1d4379d586474ab409ae065720f64f07715909a67c07dda340d1fd:0
Spending @ 2024-05-27 19:42:32 UTC 078771fb523eacd3a1e04f4e5101c42fbc2afe0821ff9ecb0f69a2e49e6e3ff3:73
|
Funding @ 2024-05-03 01:15:33 UTC faa5f6bfbef238cbaefcc13e98e10bbb94504a00150edad0c4f021cc9dae6447:0
Spending @ 2024-05-05 18:17:09 UTC 5e4ccfadb08875e5d6e25c06ad707cb4bd140c6505635d30d8a22b75860ea583:86
|
Funding @ 2024-04-29 14:07:32 UTC f031207a10ebbbe23c1ea3d16c44421e189668bac6be1ad282ce080d243f60be:0
Spending @ 2024-04-30 08:34:05 UTC 06641f8114fbe6e89195c61a7c41609047504dc1e6079cf4f7ffceb39a2e1d90:67
|
Funding @ 2024-02-24 06:25:49 UTC 1bb847d883f3845d1f76e11ccfad779eac79536950173b47760ad6e9fab90e34:0
Spending @ 2024-02-28 06:30:13 UTC f77bcf99358bb60b2ceab63373e1d286ebedaeb296e16770c39e139dd03e60cf:1
|
Funding @ 2024-02-12 19:46:34 UTC 5bb6f452d07952b7b836ffc2016e9bf2346f4617e7f347884c67659f083a062a:0
Spending @ 2024-02-15 06:48:31 UTC bca62346af960c2c9d215ecbda43174affe66136d1a576c2133c0344a3e58823:39
|
Funding @ 2023-09-23 08:27:35 UTC 5f2f01af95c2b2f880dbb9baa8e3a547b04d3a726331e3f34860ef728d84dfb7:0
Spending @ 2023-09-23 14:12:23 UTC 472b0ca61cf3a39162b467d28685b7ae2ad5762b3f8d7591f53c15d0bd5ded22:28
|
Funding @ 2023-09-22 01:59:28 UTC 540679571f20daa39147c45933b6fb7c770969f3e2b05300b3d27d1b9761da22:0
Spending @ 2023-09-23 01:04:41 UTC be8cf9d9b892fce182450a64495fbb60b8fb26bfa83f097fa3457d22162e41b8:0
|
Funding @ 2023-07-29 08:01:48 UTC efeb2a4ad72b4126e0d09d7c21d2ba29bbfb4dda33d2fa3d8e89ded05fe7c9c7:0
Spending @ 2023-07-29 22:02:41 UTC c553e4db76fb2a23b07c3cee49cda376e52be42cfa0eacc775feb00a8a31fda8:84
|